Mika Tsujimoto

Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases

Akimitsu Miyauchi, Toshio Matsumoto, Toshitsugu Sugimoto et al. · Bone · 2010 · 147 citations

Medicine, Orthopedic Surgery, Pharmacotherapy +16

PINP as an aid for monitoring patients treated with teriparatide

Mika Tsujimoto, Peiqi Chen, Akimitsu Miyauchi et al. · Bone · 2010 · 93 citations

Pharmacy, Pharmacotherapy, Therapeutic Drug Monitoring +3

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

Akimitsu Miyauchi, Toshio Matsumoto, Hirofumi Shigeta et al. · Journal of Bone and Mineral Metabolism · 2008 · 43 citations

Medicine, Pharmacology, Pharmacotherapy +17

Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS)

Satoshi Soen, Saeko Fujiwara, Ryoichi Takayanagi et al. · Current Medical Research and Opinion · 2017 · 37 citations

Medicine, Orthopedic Surgery, Pharmacotherapy +17

Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosis

Takanori Yamamoto, Mika Tsujimoto, Etsuro Hamaya et al. · Journal of Bone and Mineral Metabolism · 2012 · 27 citations

Medicine, Pharmacokinetics, Pharmacotherapy +16